First-line gefitinib therapy for elder advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Multicenter phase II trial (NEJ 003 study).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7561 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7561-7561 ◽

Author(s):

Y. Minegishi ◽

M. Maemondo ◽

S. Okinaga ◽

N. Morikawa ◽

A. Inoue ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Multicenter Phase ◽

Epidermal Growth

Download Full-text

Final analysis of phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations

Annals of Oncology ◽

10.1093/annonc/mdx671.032 ◽

2017 ◽

Vol 28 ◽

pp. x136

Author(s):

A. Tanaka ◽

A. Tamiya ◽

M. Tamiya ◽

S. Morita ◽

T. Shiroyama ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Final Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations

Medical Oncology ◽

10.1007/s12032-014-0474-x ◽

2015 ◽

Vol 32 (3) ◽

Author(s):

Akihiro Tamiya ◽

Motohiro Tamiya ◽

Takayuki Shiroyama ◽

Nobuhiko Saijo ◽

Takeshi Nakatani ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Rationale and design of a phase II trial of osimertinib as first-line treatment for elderly patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer (SPIRAL-0 study)

Translational Lung Cancer Research ◽

10.21037/tlcr.2019.11.19 ◽

2019 ◽

Vol 8 (6) ◽

pp. 1086-1090

Author(s):

Yusuke Chihara ◽

Tadaaki Yamada ◽

Junji Uchino ◽

Nobuyo Tamiya ◽

Yoshiko Kaneko ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Line Treatment ◽

Small Cell Lung ◽

Epidermal Growth ◽

First Line Treatment

Download Full-text

Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-020-03344-1 ◽

2020 ◽

Author(s):

Kosuke Kashiwabara ◽

Shinji Fujii ◽

Shinsuke Tsumura ◽

Kazuhiko Sakamoto

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Epidermal Growth Factor Receptor ◽

Retrospective Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR): Toxicity evaluation.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7078 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7078-7078 ◽

Author(s):

J. W. Neal ◽

N. A. Pennell ◽

B. W. Goodgame ◽

M. Lanuti ◽

R. S. Heist ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Toxicity Evaluation ◽

Multicenter Phase ◽

Epidermal Growth

Download Full-text

The SELECT trial: A multicenter phase II trial of adjuvant erlotinib (E) in patients with resected, early-stage non-small cell lung cancer (NSCLC) and confirmed mutations in the epidermal growth factor receptor (EGFR).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps209 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS209-TPS209 ◽

Author(s):

N. A. Pennell ◽

J. W. Neal ◽

R. Govindan ◽

P. A. Janne ◽

T. L. Evans ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Early Stage ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Multicenter Phase ◽

Epidermal Growth ◽

Download Full-text

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

British Journal of Cancer ◽

10.1038/sj.bjc.6603393 ◽

2006 ◽

Vol 95 (8) ◽

pp. 998-1004 ◽

Author(s):

H Asahina ◽

◽

K Yamazaki ◽

I Kinoshita ◽

N Sukoh ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth

Download Full-text

Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients

Cancer Medicine ◽

10.1002/cam4.3733 ◽

2021 ◽

Author(s):

Wen‐Qian Li ◽

Ling‐Yu Li ◽

Jin Chai ◽

Jiu‐Wei Cui

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Effectiveness Analysis ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

Drugs - Real World Outcomes ◽

10.1007/s40801-021-00243-w ◽

2021 ◽

Author(s):

Kristof Cuppens ◽

◽

Liesbet Lodewyckx ◽

Ingel Demedts ◽

Lore Decoster ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Reveal Study ◽

Epidermal Growth ◽

Download Full-text

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

Oncology Reports ◽

10.3892/or.7.3.603 ◽

2000 ◽

Author(s):

Y Ohsaki ◽

S Tanno ◽

Y Fujita ◽

E Toyoshima ◽

S Fujiuchi ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Receptor Expression ◽

Small Cell Lung ◽

P53 Overexpression ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text